27752082|t|Inhibition of STEP61 ameliorates deficits in mouse and hiPSC -based schizophrenia models
27752082|a|The brain - specific tyrosine phosphatase, STEP (STriatal-Enriched protein tyrosine Phosphatase) is an important regulator of synaptic function. STEP normally opposes synaptic strengthening by increasing N-methyl D-aspartate glutamate receptor (NMDAR) internalization through dephosphorylation of GluN2B and inactivation of the kinases extracellular signal-regulated kinase 1 / 2 and Fyn. Here we show that STEP61 is elevated in the cortex in the Nrg1(+/-) knockout mouse model of schizophrenia (SZ). Genetic reduction or pharmacological inhibition of STEP prevents the loss of NMDARs from synaptic membranes and reverses behavioral deficits in Nrg1(+/-) mice. STEP61 protein is also increased in cortical lysates from the central nervous system - specific ErbB2 / 4 mouse model of SZ, as well as in human induced pluripotent stem cell (hiPSC)-derived forebrain neurons and Ngn2 - induced excitatory neurons, from two independent SZ patient cohorts. In these selected SZ models, increased STEP61 protein levels likely reflect reduced ubiquitination and degradation. These convergent findings from mouse and hiPSC SZ models provide evidence for STEP61 dysfunction in SZ .Molecular Psychiatry advance online publication, 18 October 2016; doi:10.1038/mp.2016.163.
27752082	0	10	Inhibition	T044	C0021469
27752082	14	20	STEP61	T116,T126	C3883719
27752082	21	32	ameliorates	T080	C0205556
27752082	33	41	deficits	T080	C2987487
27752082	45	50	mouse	T015	C0025929
27752082	55	60	hiPSC	T025	C3658289
27752082	68	81	schizophrenia	T048	C0036341
27752082	82	88	models	T050	C0012644
27752082	93	98	brain	T023	C0006104
27752082	101	109	specific	T080	C0205369
27752082	110	130	tyrosine phosphatase	T116,T126	C0085536
27752082	132	136	STEP	T116,T126	C3883719
27752082	138	184	STriatal-Enriched protein tyrosine Phosphatase	T116,T126	C3883719
27752082	202	211	regulator	T077	C1704735
27752082	215	232	synaptic function	T043	C0027793
27752082	234	238	STEP	T116,T126	C3883719
27752082	256	264	synaptic	T030	C0039062
27752082	265	278	strengthening	T080	C0205556
27752082	282	292	increasing	T081	C0205217
27752082	293	332	N-methyl D-aspartate glutamate receptor	T116,T192	C0080093
27752082	334	339	NMDAR	T116,T192	C0080093
27752082	341	356	internalization	T067	C0599281
27752082	365	382	dephosphorylation	T044	C3160734
27752082	386	392	GluN2B	T116,T123	C1741283
27752082	397	409	inactivation	T044	C0314679
27752082	417	424	kinases	T116,T126	C0031727
27752082	425	464	extracellular signal-regulated kinase 1	T116,T126	C0082529
27752082	467	468	2	T116,T126	C0170168
27752082	473	476	Fyn	T116,T126	C1530914
27752082	496	502	STEP61	T116,T126	C3883719
27752082	506	514	elevated	T080	C3163633
27752082	522	528	cortex	T023	C1176472
27752082	536	545	Nrg1(+/-)	T028	C1367656
27752082	546	554	knockout	T050	C1522225
27752082	555	566	mouse model	T050	C2986594
27752082	570	583	schizophrenia	T048	C0036341
27752082	585	587	SZ	T048	C0036341
27752082	590	597	Genetic	T169	C0314603
27752082	598	607	reduction	T061	C0441610
27752082	611	626	pharmacological	T169	C0205464
27752082	627	637	inhibition	T052	C3463820
27752082	641	645	STEP	T116,T126	C3883719
27752082	646	654	prevents	T169	C1292733
27752082	667	673	NMDARs	T116,T192	C0080093
27752082	679	697	synaptic membranes	T026	C0039063
27752082	711	730	behavioral deficits	T048	C0004930
27752082	734	743	Nrg1(+/-)	T028	C1367656
27752082	744	748	mice	T015	C0025929
27752082	750	764	STEP61 protein	T116,T126	C3883719
27752082	773	782	increased	T081	C0205217
27752082	786	794	cortical	T023	C1176472
27752082	795	802	lysates	T072	C1881488
27752082	812	834	central nervous system	T022	C3714787
27752082	837	845	specific	T080	C0205369
27752082	846	851	ErbB2	T116,T126,T192	C0069515
27752082	854	855	4	T116,T126,T192	C0214098
27752082	856	867	mouse model	T050	C2986594
27752082	871	873	SZ	T048	C0036341
27752082	889	924	human induced pluripotent stem cell	T025	C3658289
27752082	926	931	hiPSC	T025	C3658289
27752082	941	950	forebrain	T023	C0085140
27752082	951	958	neurons	T025	C0027882
27752082	963	967	Ngn2	T028	C1422204
27752082	970	977	induced	T169	C0205263
27752082	978	996	excitatory neurons	T025	C0027882
27752082	1007	1018	independent	T169	C0332291
27752082	1019	1021	SZ	T048	C0036341
27752082	1022	1029	patient	T101	C0030705
27752082	1030	1037	cohorts	T098	C0599755
27752082	1048	1056	selected	T052	C1707391
27752082	1057	1059	SZ	T048	C0036341
27752082	1060	1066	models	T050	C0012644
27752082	1068	1077	increased	T081	C0205217
27752082	1078	1084	STEP61	T116,T126	C3883719
27752082	1085	1099	protein levels	T059	C0542493
27752082	1115	1122	reduced	T080	C0392756
27752082	1123	1137	ubiquitination	T044	C1519751
27752082	1142	1153	degradation	T044	C0597297
27752082	1161	1171	convergent	T080	C0205556
27752082	1172	1180	findings	T033	C0243095
27752082	1186	1191	mouse	T015	C0025929
27752082	1196	1201	hiPSC	T025	C3658289
27752082	1202	1204	SZ	T048	C0036341
27752082	1205	1211	models	T050	C0012644
27752082	1212	1219	provide	T052	C1999230
27752082	1220	1228	evidence	T078	C3887511
27752082	1233	1239	STEP61	T116,T126	C3883719
27752082	1240	1251	dysfunction	T077	C3887504
27752082	1255	1257	SZ	T048	C0036341